2017 Regular Session
|At the request of:
|(at the request of Rocky Dallum, Tonkon Torp LLC)
|Relating to opioid analgesic drug products.
|Requires health benefit plan that covers opioid analgesic drug products to cover abuse-deterrent opioid analgesic drug products, at no greater cost to insured than other preferred drugs under plan, and specifies other requirements regarding coverage.
|May Have Fiscal Impact, But No Statement Yet Issued
|May Have Revenue Impact, But No Statement Yet Issued
|Staff Measure Summary / Impact Statements
|In Senate Committee
|Senate Committee On Health Care
|Potential Conflicts of Interest/Vote Explanations:
|Potential Conflicts of Interest/Vote Explanation Documents